Propolis: A review of its anti-inflammatory and healing actions

Journal of Venomous Animals and Toxins Including Tropical Diseases

Volumn 13, Issue 4, 2007, Pages 697-700

  Ramos, A F N ^a   De Miranda, João Luiz ^a  

^a UNIVERSIDADE FEDERAL DOS VALES DO JEQUITINHONHA E MUCURI   (Brazil)

Author keywords

Anti inflammatory action; Apis mellifera; Healing properties; Inflammation; Propolis

Indexed keywords

APIS MELLIFERA;

EID: 38349126263     PISSN: 16789199     EISSN: 16789199     Source Type: Journal    
DOI: 10.1590/s1678-91992007000400002     Document Type: Review

References (47)

1. ACKERMANN T. Fast chromatography study of propolis crudes. Food Chemistry, 1991, 42, 135-8.
2. ALCICI NMF. Heavy metals in propolis: practical and simple procedures to reduce the lead in the Brazilian propolis. Chemical Abstracts, 1996, 127, 236-7.
3. ALMEIDA EC., MENEZES H. Anti-inflammatory activity of propolis extracts: a review. J. Venom. Anim. Toxins, 2002, 8, 191-212.
4. BANKOVA V. Chemical diversity of propolis and the problem of standardization. J. Ethnopharmacol., 2005, 100, 114-7.
5. BANKOVA VS., POPOV SS., MAREKOV NL. Isopentenyl cinnamates from poplar buds and propolis. Phytochemistry, 1989, 28, 871-3.
6. BORRELLI F., MAFFIA P., PINTO L., IANARO A., RUSSO A., CAPASSO F., IALENTI A. Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. Fitoterapia, 2002, 73, 53-63.
7. CASTALDO S., CAPASSO F. Propolis, an old remedy used in modern medicine. Fitoterapia, 2002, 73, 1-6.
8. CELIK S., GORUR S., ASLANTAS O., ERDOGAN S., OCAK S., HAKVERDI S. Caffeic acid phenethyl ester suppresses oxidative stress in Escherichia coli-induced pyelonephritis in rats. Mol. Cell. Biochem., 2007, 297, 131-8.
9. DEVASAGAYAM TP., TILAK JC., BOLOOR KK., SANE KS., GHASKADBI SS., LELE RD. Free radicals and antioxidants in human health: current status and future prospects. J. Assoc. Physicians India, 2004, 52, 794-804.
10. DIAZ JCQ., RODRÍGUES OA., VELÁZQUEZ MD., MILIÁ NML. Empleo de la tintura de propóleo en la cura de heridas sépticas faciales. Rev. Cuba Estomatol., 1997, 34, 347-51.
11. DIAZ NJ., QUEVEDO AO., LUNA SB. Determination of Fe, Mn, Zn, and Cu in an ethanolic extract of Cuban propolis. Rev. CENIC. Ciências Químicas, 1997, 28, 93-5.
12. FERNANDES JUNIOR A., SUGIZAKI MF., FOGO ML., FUNARE SRC., LOPES CAM. In vitro activity of propolis against bacterial and yeast pathogens isolated from human infections. J. Venom. Anim. Toxins, 1995, 1, 63-9.
13. GHISALBERTI EL. Propolis: a review. Bee World, 1979, 60, 59-84.
14. GUPTA R., VERMA I., SHARMA S., GANGULY NK. Prevention of tissue injury in an ascending mouse model of chronic pyelonephritis-role of free radical scavengers. Comp. Immunol. Microbiol. Infect. Dis., 2004, 27, 225-34.
15. HAVSTEEN BH. The biochemistry and medical significance of the flavonoids. Pharmacol. Therapeutics, 2002, 96, 67-202.
16. HU F., HEPBURN HR., LI Y., CHEN M., RADLOFF SE., DAYA S. Effects of ethanol and water extracts of propolis (bee glue) on acute inflammatory animal models. J. Ethnopharmacol., 2005, 100, 276-83.
17. IVANOVSKA N., STEFANO Z., VALEVA V., NEYCHEV H. Immunomodulatory action of propolis: VII. A comparative study on cinnamic and caffeic acid lysine derivates. Biol. Immun., 1993, 46, 115-7.
18. KROL W., SCHELLER S., CZUBA Z., MATSUMO T., ZYDOWICZ G., SHANI J., MOS M. Inhibition of neutrophils' chemiluminescence by ethanol extract of propolis (EEP) and its phenolic components. J. Ethnopharmacol., 1996, 55, 19-25.
19. KUMAZAWA S., HAMASAKA T., NAKAYAMA T. Antioxidant activity of propolis of various geographic origins. Food Chemistry, 2004, 84, 329-39.
20. LEE KW., CHUN KS., LEE JS., KANG KS., SURH YJ., LEE HJ. Inhibition of cyclooxygenase-2 expression and restoration of gap junction intercellular communication in H-ras-transformed rat liver epithelial cells by caffeic acid phenethyl ester. Ann. N. Y. Acad. Sci., 2004, 1030, 501-7.
21. LOPES RE., CHAPADEIRO E., RASO P., TAFURI LW. Patologia. Rio de Janeiro: Guanabara, 1987: 67-112.
22. MAMDELBAUM SH., SANTIS EP. Cicatrização: conceitos atuais e recursos auxiliares - Parte I. An. Bras. Dermatol., 2003, 78, 393-410.
23. MARCUCCI MC. Propolis: Chemical composition, biological properties and therapeutic activity. Apidologie, 1995, 26, 83-99.
24. MARCUCCI MC., RODRIGUEZ J., FERREREZ F., BANKOVA V., GROTOR., POPOV S. Chemical composition of Brazilian propolis from São Paulo State. Z. Neturforsch. Sect. C. Biosc., 1998, 53, 117-9.
25. MARQUELE FD., DI MAMBRO VM., GEORGETTI SR., CASAGRANDE R., VALIM YM., FONSECA MJ. Assessment of the antioxidant activities of Brazilian extracts of propolis alone and in topical pharmaceutical formulations. J. Pharm. Biomed. Anal., 2005, 39, 455-62.
26. MATHEWS KA., BINNINGTON AG. Wound management using honey. Comp. Cont. Educ. Pract. Vet., 2002, 24, 53-60.
27. MCGEE JO., ISAACSON PG., WRIGHT NA. Principles of Pathology. Oxford: Oxford University Press, 1994, 1, 378-9.
28. MENEZES H. Própolis: uma revisão dos recentes estudos de suas propriedades farmacológicas. Arq. Inst. Biol., 2005, 72, 405-11.
29. MIRZOEVA OK., CALDER PC. The effect of propolis and its components on eicosanoid production during the inflammatory response. Prostaglandins Leukot. Essent. Fatty Acids, 1996, 55, 441-9.
30. MIYATAKA H., NISHIKI M., MATSUMOTO H., FIJIMOTO T., MATSUKA M., SATOH T. Evaluation of propolis. I. Evaluation of Brazilian and Chinese propolis by enzymatic and physico-chemical methods. Biol. Pharm. Bull., 1997, 20, 496-501.
31. MONTI M., BERTI E., CARMINATI G., CUSINI M. Occupational and cosmetic dermatitis from propolis. Contact Dermatitis, 1983, 9, 163.
32. NAGAOKA T., BANSKOTA AH., TEZUKA Y., MIDORIKAWA K., MATSUSHIGE K., KADOTA S. Caffeic acid phenethyl ester (CAPE) analogues: potent nitric oxide inhibitors from the Netherlands propolis. Biol. Pharm. Bull., 2003, 26, 487-91.
33. ORSI RO., FUNARI RSC., SOARES AMVC., CALVI AS., OLIVEIRA SL., SFORCIN JM., BANKOVA V. Immunomodulatory action of propolis on macrophage activation. J. Venom. Anim. Toxins, 2000, 6, 205-19.
34. PARK YK., IKEGAKI M., ABREU JA., ALCICI NM. Estudo da preparação dos extratos de própolis e suas aplicações. Ci. Tecnol. Aliment, 1998, 18, 313-8.
35. PARK YK., KOO MH, IKEGARI M., CONTADO JL. Comparison of the flavonoid aglycone contents of Apis mellifera propolis from various regions of Brazil. Arq. Biol. Tecnol., 1997, 40, 97-106.
36. PEREZ-TAMAYO R. Introduccion a la Patologia. Buenos Aires: Editoria Médica Panamericana, 1987: 670.
37. SALATINO A., TEIXEIRA EW., NEGRI G., MESSAGE D. Origin and chemical variation of Brazilian propolis. Evid. Based Complement. Alternat. Med., 2005, 2, 33-8.
38. SCHELLER S., GADZA G., KROL W., CZUBA Z., ZAJUSZ A., GABRYS J., SHANI J. The ability of ethanolic extract of propolis (EEP) to protect mice against gamma irradiation. Z. Neturforsch. Sect. C. Biosc., 1989, 44, 1040-52.
39. SFORCIN JM., KANENO R., FUNARI SRC. Absence of seasonal effect on the immunomodulatory action of Brazilian propolis on natural killer activity. J. Venom. Anim. Toxins, 2002, 8, 19-29.
40. SILICI S., KUTLUCA S. Chemical composition and antibacterial activity of propolis collected by three different races of honeybees in the same region. J. Ethnopharmacol., 2005, 99, 69-73.
41. SONG YS., PARK EH., HUR GM., RYU YS., LEE YS., LEE JY., KIM YM., JIN C. Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett., 2002, 175, 53-61.
42. SOSA S., BARICEVIC D., CINCO M., PADOVAN D., TUBARO A., DELLA LOGGIA R. Preliminary investigation on the anti-inflammatory and anti-microbial activities of propolis. Pharm. Pharmacol. Lett., 1997, 4, 168-71.
43. SURH YJ., CHUN KS., CHA HH., HAN SS., KEUM YS., PARK KK., LEE SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NK-kB activation. Mutat. Res., 2001, 480-481, 243-68.
44. SUTTA J., HANKO J., JANDA J., TKAC J. Experimental and clinical experiences in the treatment of wounds in domestic animals by local application of an alcoholic solution of propolis. Bratislava: Folia Veterinaria, 1974, 18, 143-147.
45. TEIXEIRA EW., NEGRI G., MEIRA RM., MESSAGE D., SALATINO A. Plant origin of green propolis: Bee behavior, plant anatomy and chemistry. Evid. Based Complement. Alternat. Med., 2005, 2, 85-92.
46. TOSI B., DONINI A., ROMAGNOLI C., BRUNI A. Antimicrobial activity of some commercial extracts of propolis prepared with different solvents. Phytother. Res., 1996, 1014, 335-6.
47. WU KK-Y. Biochemical pharmacology of nonsteroidal anti-inflammatory drugs. Biochem. Pharmacol., 1998, 55, 543-7.